Interstitial lung disease during trimethoprim/sulfamethoxazole administration

Syota Yuzurio, Naokatsu Horita, Yutaro Shiota, Arihiko Kanehiro, Mitsune Tanimoto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We studied clinical and radiographic features of interstitial lung disease (ILD) during trimethoprim/ sulfamethoxazole (TMP/SMX) administration. Ten patients who had received prednisolone treatment for underlying diffuse pulmonary disease showed various ILDs after introduction of TMP/SMX. The radiographic features of the ILDs were not consistent with infectious disease or exacerbation of the underlying disease, and these diagnoses were excluded radiographically and on clinical grounds during the differential diagnosis of the ILDs. These ILDs emerged relatively early after introduction of TMP/SMX, which is consistent with the former case report of drug-induced ILD (DI-ILD) caused by TMP/SMX. Therefore DI-ILDs caused by TMP/SMX were suspected in these cases. In most of these cases, the ILDs were clinically mild and disappeared immediately although administration of TMP/ SMX was continued.

Original languageEnglish
Pages (from-to)181-187
Number of pages7
JournalActa Medica Okayama
Volume64
Issue number3
Publication statusPublished - Jul 2010

Fingerprint

Pulmonary diseases
Interstitial Lung Diseases
Sulfamethoxazole Drug Combination Trimethoprim
Prednisolone
Lung Diseases
Communicable Diseases
Disease Progression
Differential Diagnosis
Pharmaceutical Preparations

Keywords

  • Clinical characteristic
  • Drug-induced interstitial lung disease
  • Radiographic findings
  • Trimethoprim/sulfamethoxazole

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Yuzurio, S., Horita, N., Shiota, Y., Kanehiro, A., & Tanimoto, M. (2010). Interstitial lung disease during trimethoprim/sulfamethoxazole administration. Acta Medica Okayama, 64(3), 181-187.

Interstitial lung disease during trimethoprim/sulfamethoxazole administration. / Yuzurio, Syota; Horita, Naokatsu; Shiota, Yutaro; Kanehiro, Arihiko; Tanimoto, Mitsune.

In: Acta Medica Okayama, Vol. 64, No. 3, 07.2010, p. 181-187.

Research output: Contribution to journalArticle

Yuzurio, S, Horita, N, Shiota, Y, Kanehiro, A & Tanimoto, M 2010, 'Interstitial lung disease during trimethoprim/sulfamethoxazole administration', Acta Medica Okayama, vol. 64, no. 3, pp. 181-187.
Yuzurio S, Horita N, Shiota Y, Kanehiro A, Tanimoto M. Interstitial lung disease during trimethoprim/sulfamethoxazole administration. Acta Medica Okayama. 2010 Jul;64(3):181-187.
Yuzurio, Syota ; Horita, Naokatsu ; Shiota, Yutaro ; Kanehiro, Arihiko ; Tanimoto, Mitsune. / Interstitial lung disease during trimethoprim/sulfamethoxazole administration. In: Acta Medica Okayama. 2010 ; Vol. 64, No. 3. pp. 181-187.
@article{dba9825e43544fe8814829094d0ecbd8,
title = "Interstitial lung disease during trimethoprim/sulfamethoxazole administration",
abstract = "We studied clinical and radiographic features of interstitial lung disease (ILD) during trimethoprim/ sulfamethoxazole (TMP/SMX) administration. Ten patients who had received prednisolone treatment for underlying diffuse pulmonary disease showed various ILDs after introduction of TMP/SMX. The radiographic features of the ILDs were not consistent with infectious disease or exacerbation of the underlying disease, and these diagnoses were excluded radiographically and on clinical grounds during the differential diagnosis of the ILDs. These ILDs emerged relatively early after introduction of TMP/SMX, which is consistent with the former case report of drug-induced ILD (DI-ILD) caused by TMP/SMX. Therefore DI-ILDs caused by TMP/SMX were suspected in these cases. In most of these cases, the ILDs were clinically mild and disappeared immediately although administration of TMP/ SMX was continued.",
keywords = "Clinical characteristic, Drug-induced interstitial lung disease, Radiographic findings, Trimethoprim/sulfamethoxazole",
author = "Syota Yuzurio and Naokatsu Horita and Yutaro Shiota and Arihiko Kanehiro and Mitsune Tanimoto",
year = "2010",
month = "7",
language = "English",
volume = "64",
pages = "181--187",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "3",

}

TY - JOUR

T1 - Interstitial lung disease during trimethoprim/sulfamethoxazole administration

AU - Yuzurio, Syota

AU - Horita, Naokatsu

AU - Shiota, Yutaro

AU - Kanehiro, Arihiko

AU - Tanimoto, Mitsune

PY - 2010/7

Y1 - 2010/7

N2 - We studied clinical and radiographic features of interstitial lung disease (ILD) during trimethoprim/ sulfamethoxazole (TMP/SMX) administration. Ten patients who had received prednisolone treatment for underlying diffuse pulmonary disease showed various ILDs after introduction of TMP/SMX. The radiographic features of the ILDs were not consistent with infectious disease or exacerbation of the underlying disease, and these diagnoses were excluded radiographically and on clinical grounds during the differential diagnosis of the ILDs. These ILDs emerged relatively early after introduction of TMP/SMX, which is consistent with the former case report of drug-induced ILD (DI-ILD) caused by TMP/SMX. Therefore DI-ILDs caused by TMP/SMX were suspected in these cases. In most of these cases, the ILDs were clinically mild and disappeared immediately although administration of TMP/ SMX was continued.

AB - We studied clinical and radiographic features of interstitial lung disease (ILD) during trimethoprim/ sulfamethoxazole (TMP/SMX) administration. Ten patients who had received prednisolone treatment for underlying diffuse pulmonary disease showed various ILDs after introduction of TMP/SMX. The radiographic features of the ILDs were not consistent with infectious disease or exacerbation of the underlying disease, and these diagnoses were excluded radiographically and on clinical grounds during the differential diagnosis of the ILDs. These ILDs emerged relatively early after introduction of TMP/SMX, which is consistent with the former case report of drug-induced ILD (DI-ILD) caused by TMP/SMX. Therefore DI-ILDs caused by TMP/SMX were suspected in these cases. In most of these cases, the ILDs were clinically mild and disappeared immediately although administration of TMP/ SMX was continued.

KW - Clinical characteristic

KW - Drug-induced interstitial lung disease

KW - Radiographic findings

KW - Trimethoprim/sulfamethoxazole

UR - http://www.scopus.com/inward/record.url?scp=77954699502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954699502&partnerID=8YFLogxK

M3 - Article

C2 - 20596129

AN - SCOPUS:77954699502

VL - 64

SP - 181

EP - 187

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 3

ER -